<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet12863</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-12863</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Цитокины и регуляция метаболизма глюкозы и липидов при ожирении</article-title><trans-title-group xml:lang="en"><trans-title>Cytokines and regulation of glucose and lipid metabolism in the obesity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0261-970X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербаков</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Scherbakov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Щербаков Владимир Иванович, доктор медицинских наук </p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Vladimir I. Scherbakov, MD, PhD</p><p>Novosibirsk</p></bio><email xlink:type="simple">Scherbakov_VI@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5477-3445</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скосырева</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Skosyreva</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Скосырева Галина Александровна, доктор медицинских наук </p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Galina А. Skosyreva, MD, PhD</p><p>Novosibirsk</p></bio><email xlink:type="simple">skosyreva43@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0990-0078</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рябиченко</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryabichenko</surname><given-names>T. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рябиченко Татьяна Ивановна, доктор медицинских наук </p><p>630108, Новосибирск, 1-й переулок Пархоменко, д. 6 </p><p> </p></bio><bio xml:lang="en"><p>Tatyana I. Ryabichenko, MD, PhD</p><p>6, 1 Per. Parchomenko, 630108 Novosibirsk</p><p> </p></bio><email xlink:type="simple">2925871@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9834-1799</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Обухова</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Obukhova</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Обухова Ольга Олеговна, доктор медицинских наук </p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Olga O. Obukhova, MD, PhD</p><p>Novosibirsk</p></bio><email xlink:type="simple">trio188@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральный исследовательский центр Фундаментальной и трансляционной медицины</institution></aff><aff xml:lang="en"><institution>Federal Research Center of Fundamental and Translational Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>06</day><month>12</month><year>2022</year></pub-date><volume>19</volume><issue>3</issue><fpage>317</fpage><lpage>323</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Щербаков В.И., Скосырева Г.А., Рябиченко Т.И., Обухова О.О., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Щербаков В.И., Скосырева Г.А., Рябиченко Т.И., Обухова О.О.</copyright-holder><copyright-holder xml:lang="en">Scherbakov V.I., Skosyreva G.A., Ryabichenko T.I., Obukhova O.O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/12863">https://www.omet-endojournals.ru/jour/article/view/12863</self-uri><abstract><p>В статье представлены данные о влиянии роли цитокинов различной направленности на метаболизм глюкозы и липидов при ожирении. Изменение основной парадигмы в отношении жировой ткани способствовало ряду открытий последнего времени. Это касается таких базовых понятий, как здоровый и больной адипоцит, и, как следствие этого, изменения их метаболизма при воздействии цитокинов. Выделение такого понятия, как органокины, показывает, что, несмотря на общие черты цитокиновой регуляции, в каждом органе существует своя специфика, важным разделом которой является представление о гетерогенности жировой ткани. Расширяются знания о функции жировой ткани, локализованной в различных компартментах организма. Представлены данные, показывающие возможность перехода одного вида жировой ткани в другую. Показан возможный механизм, связывающий воспаление жировой ткани и формирование инсулинорезистентности. Механизм развития инсулинорезистентности тесно связан с провоспалительными цитокинами, нарушающими прохождение инсулинового сигнала, сопровождающегося снижением работы глюкозных транспортеров. Уменьшение поступления глюкозы в клетки ведет к изменению уровня гликолиза, повышению окисления жирных кислот. Цитокины способны участвовать в процессе конверсии одних клеток в другие, что происходит как при физиологическом, так и патологическом процессе.</p><p> </p></abstract><trans-abstract xml:lang="en"><p>The article presents data of the influence of cytokines of different directions of glucose and lipid metabolism in obesity. A change of the basic paradigm regarding adipose tissue has contributed to a number of recent discoveries. This concerns such basic concepts as healthy and diseased adipocytes, and, as a consequence, changes of their metabolism under the influence of cytokins. Distinguishing the concept of organokines demonstrates that despite the common features of cytokine regulation, each organ has its own specifics features of cytokine regulation, each organ has its own specific an important section of this concept is the idea of the heterogeneity of adipose tissue. Knowledge of the function of adipose tissue localized in different compartments of the body is expanding. There are date about the possibility of transition of one type of adipose tissue to another. A possible mechanism linking adipose tissue inflammation and the formation of insulin resistance (IR) is presented in this paper. The mechanism of IR development is closely connected with to proinflammatory cytokins disordering the insulin signal, accompanied by a decrease of the work of glucose transporters. A decrease of the income of glucose into cells leads to a change of glycolysis level to an increase of the fatty acids oxidation. Cytokins are able to participate in the process of the collaboration of some cells with others, that occurs both during physiological and pathological process.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>цитокины</kwd><kwd>метаболизм</kwd><kwd>жировая ткань</kwd></kwd-group><kwd-group xml:lang="en"><kwd>obesity</kwd><kwd>cytokines</kwd><kwd>metabolism</kwd><kwd>adipose tissue</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Финансирование исследования проводилось за счет государственного задания Минобрнауки России (№1021050701196-1-3.2.27;3.3.8)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng L, Wang J, Dai H, et al. Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus. Adipocyte. 2021;10(1):48-65. doi: https://doi.org/10.1080/21623945.2020.1870060</mixed-citation><mixed-citation xml:lang="en">Cheng L, Wang J, Dai H, et al. Brown and beige adipose tissue: a novel therapeutic strategy for obesity and type 2 diabetes mellitus. Adipocyte. 2021;10(1):48-65. doi: https://doi.org/10.1080/21623945.2020.1870060</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Коннон С.Р.Д., Союнов М.А. Бесплодие в эру ожирения: эпидемиология и методы его определения // Акушерство и гинекология: новости, мнения, обучение. — 2018. — Т. 6. — №3. — С. 105-112. doi: https://doi.org/10.24411/2303-9698-2018-13012</mixed-citation><mixed-citation xml:lang="en">Connon SRD, Soyunov MA. Infertility in the era of obesity: epidemiology and methods of its determination. Obstetrics and Gynecology: News, Opinions, Training. 2018:6(3):105-112. (In Russ.). doi: https://doi.org/10.24411/2303-9698-2018-13012</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Бокова Т.А. Факторы риска формирования метаболического синдрома у детей с ожирением // Российский вестник перинатологии и педиатрии. — 2018. — Т. 63. — №3. — С. 64-69. doi: https://doi.org/10.21508/1027-4065-2018-63-3-64-69</mixed-citation><mixed-citation xml:lang="en">Bokova TA. Risk factors for the formationo of metabolic syndromein children with obesity. Russian Bulletin of Perinatology and Pediatrics. 2018:63(3):64-69 (in Russ.). doi: https://doi.org/10.21508/1027-4065-2018-63-3-64-69</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cheong LY, XuA. Intercellular and inter-organ crosstalk in browning of white adipose tissue : molecular mechanism and therapeutic complications. J Mol Cell Biol. 2021;13(7):466-479. doi: https://doi.org/10.1093/jmcb/mjab038</mixed-citation><mixed-citation xml:lang="en">Cheong LY, XuA. Intercellular and inter-organ crosstalk in browning of white adipose tissue : molecular mechanism and therapeutic complications. J Mol Cell Biol. 2021;13(7):466-479. doi: https://doi.org/10.1093/jmcb/mjab038</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Somm E, Henrichot E, Pernin A, et al. Decreased fat mass in interleukin-1 receptor antagonist–deficient mice. Diabetes. 2005;54(12):3503-3509. doi: https://doi.org/10.2337/diabetes.54.12.3503</mixed-citation><mixed-citation xml:lang="en">Somm E, Henrichot E, Pernin A, et al. Decreased fat mass in interleukin-1 receptor antagonist–deficient mice. Diabetes. 2005;54(12):3503-3509. doi: https://doi.org/10.2337/diabetes.54.12.3503</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Takaya K, Matsuda N, Asou T, Kishi K. Brown preadipocyte transplantation locally ameliorates obesity. Arch Plast Surg. 2021;48(4):440-447. doi: https://doi.org/10.5999/aps.2020.02257</mixed-citation><mixed-citation xml:lang="en">Takaya K, Matsuda N, Asou T, Kishi K. Brown preadipocyte transplantation locally ameliorates obesity. Arch Plast Surg. 2021;48(4):440-447. doi: https://doi.org/10.5999/aps.2020.02257</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Щербаков В.И., Рябиченко Т.И., Скосырева Г.А., Трунов А.Н. Механизмы внутриутробного программирования ожирения у детей // Российский вестник перинатологии и педиатрии. — 2013. — T. 19. — №5. — C. 8-14.</mixed-citation><mixed-citation xml:lang="en">Shcherbakov VI, Ryabichenko TI, Skosyreva GA, Trunov AN. Mechanisms of prenatal programming of obesity in children. Russian Bulletin of Perinatology and Pediatrics. 2013;19(5):8-14. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Поварова О.А., Городецкая Е.А., Каленикова Е.И. Медведев О.С. Метаболические маркеры и окислительный стресс в патогенезе ожирения у детей // Российский вестник перинатологии и педиатрии. — 2020. — Т. 65. — №1. — С. 22-29. doi: https://doi.org/10:21508/1027-4065-2020-65-1-22-29</mixed-citation><mixed-citation xml:lang="en">Povarova OA, Gorodetskaya EA, Kalenikova EI, Medvedev OS. Metabolic markers and oxidative stress in the pathogenesis ofobesity in children. Russian Bulletin of Perinatology and Pediatrics. 2020;65(1):22-29. (In Russ.). doi: https://doi.org/10:21508/1027-4065-2020-65-1-22-29</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Vadde R, Gupta MK, Nagaraju GP. Is Adipose Tissue an Immunological Organ? Crit Rev Immunol. 2019;39(6):481-490. doi: https://doi.org/10.1615/CritRevImmunol.2020033457</mixed-citation><mixed-citation xml:lang="en">Vadde R, Gupta MK, Nagaraju GP. Is Adipose Tissue an Immunological Organ? Crit Rev Immunol. 2019;39(6):481-490. doi: https://doi.org/10.1615/CritRevImmunol.2020033457</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yang FT, Stanford KI. Batokines: Mediators of Inter-Tissue Communication (a Mini-Review). Curr Obes Rep. 2022;11(1):1-9. doi: https://doi.org/10.1007/s13679-021-00465-7</mixed-citation><mixed-citation xml:lang="en">Yang FT, Stanford KI. Batokines: Mediators of Inter-Tissue Communication (a Mini-Review). Curr Obes Rep. 2022;11(1):1-9. doi: https://doi.org/10.1007/s13679-021-00465-7</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Qing H, Desrouleaux R, Israni-Winger K, et al. Origin and function of stress-induced IL-6 in murine models. Cell. 2020;182(2):372-387. e14. doi: https://doi.org/10.1016/j.cell.2020.05.054</mixed-citation><mixed-citation xml:lang="en">Qing H, Desrouleaux R, Israni-Winger K, et al. Origin and function of stress-induced IL-6 in murine models. Cell. 2020;182(2):372-387. e14. doi: https://doi.org/10.1016/j.cell.2020.05.054</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shi J, Fan J, Su Q, Yang Z. Cytokines and Abnormal Glucose and Lipid Metabolism. Front Endocrinol (Lausanne). 2019;10:703. doi: https://doi.org/10.3389/fendo.2019.00703</mixed-citation><mixed-citation xml:lang="en">Shi J, Fan J, Su Q, Yang Z. Cytokines and Abnormal Glucose and Lipid Metabolism. Front Endocrinol (Lausanne). 2019;10:703. doi: https://doi.org/10.3389/fendo.2019.00703</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Li L, Yang G, Shi S, et al. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine. 2009;45(1):12-19. doi: https://doi.org/10/1016/j.cyto.2008.10.006</mixed-citation><mixed-citation xml:lang="en">Li L, Yang G, Shi S, et al. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine. 2009;45(1):12-19. doi: https://doi.org/10/1016/j.cyto.2008.10.006</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Романцова Т.И., Сыч Ю.П. Иммунометаболизм и метавоспаление при ожирении // Ожирение и метаболизм. — 2019. — Т. 16. — №4. — С. 3-17. doi: https://doi.org/10.24411/2303-9698-2018-13012</mixed-citation><mixed-citation xml:lang="en">Romantsova TI, Sych YuP. Immunometabolism and meta-inflammation in obesity. Obesity and metabolism. 2019;16(4):3-17. (In Russ.) doi: https://doi.org/10.24411/2303-9698-2018-13012</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrionol Metab. 2004;89(6):2548-2556. doi: https://doi.org/10.1210/jc.2004-0395</mixed-citation><mixed-citation xml:lang="en">Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrionol Metab. 2004;89(6):2548-2556. doi: https://doi.org/10.1210/jc.2004-0395</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Trayhum P. Adipokines: inflammation and pleiotrop. doic role of white adipose tissue. Br J Nutr. 2022:127(2):161-164. doi: https://doi.org/10.1017/S0007114521003962</mixed-citation><mixed-citation xml:lang="en">Trayhum P. Adipokines: inflammation and pleiotrop. doic role of white adipose tissue. Br J Nutr. 2022:127(2):161-164. doi: https://doi.org/10.1017/S0007114521003962</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kwon H, Pessin JE. Adipokines mediate inflammaton and insulin resistance. Front Endcrinol. 2013;(4):71. doi: https://doi.org/10.3389/fendo2013.00071</mixed-citation><mixed-citation xml:lang="en">Kwon H, Pessin JE. Adipokines mediate inflammaton and insulin resistance. Front Endcrinol. 2013;(4):71. doi: https://doi.org/10.3389/fendo2013.00071</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ravussin E, Galgani JE. The implication of brown adipose tissue for humans. Annu Rev Nutr. 2011;31(1):33-47. doi: https://doi.org/10.1146/annurev-nutr-072610-145209</mixed-citation><mixed-citation xml:lang="en">Ravussin E, Galgani JE. The implication of brown adipose tissue for humans. Annu Rev Nutr. 2011;31(1):33-47. doi: https://doi.org/10.1146/annurev-nutr-072610-145209</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81-87. doi: https://doi.org/10.1097/MED.0b013e3283514e13</mixed-citation><mixed-citation xml:lang="en">Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19(2):81-87. doi: https://doi.org/10.1097/MED.0b013e3283514e13</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Michailidou Z, Gomez-Salazar M, Alexaki VI. Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease. J Innate Immun. 2022;14(1):4-30. doi: https://doi.org/10.1159/000515117</mixed-citation><mixed-citation xml:lang="en">Michailidou Z, Gomez-Salazar M, Alexaki VI. Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease. J Innate Immun. 2022;14(1):4-30. doi: https://doi.org/10.1159/000515117</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Metab. 2007;293(2):E444-E452. doi: https://doi.org/10.1152/ajpendo.00691.2006</mixed-citation><mixed-citation xml:lang="en">Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Metab. 2007;293(2):E444-E452. doi: https://doi.org/10.1152/ajpendo.00691.2006</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lorenzo M, Fernander-VeledoS, Vila- Bedmar R, et al. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci. 2008;86(14):94-104. doi: https://doi.org/10.2527/jas.2007-0462</mixed-citation><mixed-citation xml:lang="en">Lorenzo M, Fernander-VeledoS, Vila- Bedmar R, et al. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci. 2008;86(14):94-104. doi: https://doi.org/10.2527/jas.2007-0462</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rodríguez A, Ezquerro S, Méndez-Giménez L, et al. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Metab. 2015;309(8):E691-E714. doi: https://doi.org/10.1152/ajpendo.00297.2015</mixed-citation><mixed-citation xml:lang="en">Rodríguez A, Ezquerro S, Méndez-Giménez L, et al. Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol Metab. 2015;309(8):E691-E714. doi: https://doi.org/10.1152/ajpendo.00297.2015</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Giordano A, Smorlesi A, Frontini A, Barbatelli G, Cinti S. Mechanisms in endocrinology: White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur J Endocrinol. 2014;170(5):R159-R171. doi: https://doi.org/10.1530/EJE-13-0945</mixed-citation><mixed-citation xml:lang="en">Giordano A, Smorlesi A, Frontini A, Barbatelli G, Cinti S. Mechanisms in endocrinology: White, brown and pink adipocytes: the extraordinary plasticity of the adipose organ. Eur J Endocrinol. 2014;170(5):R159-R171. doi: https://doi.org/10.1530/EJE-13-0945</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kaisanlahti A, Glumoff T. Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes. J Physiol Biochem. 2019;75(1):1-10. doi: https://doi.org/10.1007/s13105-018-0658-5</mixed-citation><mixed-citation xml:lang="en">Kaisanlahti A, Glumoff T. Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes. J Physiol Biochem. 2019;75(1):1-10. doi: https://doi.org/10.1007/s13105-018-0658-5</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y, Li R, Meng Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinage p 38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63(2):514-525. doi: https://doi.org/10.2337/db13-1106</mixed-citation><mixed-citation xml:lang="en">Zhang Y, Li R, Meng Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinage p 38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63(2):514-525. doi: https://doi.org/10.23371/db 13-1106 2</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Abdullahi A, Chen P, Stanojcic M, et al. IL-6 signal from the bone marrow is required for the browning of white adipose tissue post burn injury. Shock. 2017;47(1):33-39. doi: https://doi.org/10.1097/SHK.0000000000000749</mixed-citation><mixed-citation xml:lang="en">Abdullahi A, Chen P, Stanojcic M, et al. IL-6 signal from the bone marrow is required for the browning of white adipose tissue post burn injury. Shock. 2017;47(1):33-39. doi: https://doi.org/10.1097/SHK.0000000000000749</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Annunziata C, Pirozzi C, Lama A, et al. Palmitoylethanolamide promotes white-to-beige conversion and metabolic reprogramming of adipocytes: contribution of PPAR-α. Pharmaceutics. 2022;14(2):338. doi: https://doi.org/10.3390/pharmaceutics14020338</mixed-citation><mixed-citation xml:lang="en">Annunziata C, Pirozzi C, Lama A, et al. Palmitoylethanolamide promotes white-to-beige conversion and metabolic reprogramming of adipocytes: contribution of PPAR-α. Pharmaceutics. 2022;14(2):338. doi: https://doi.org/10.3390/pharmaceutics14020338</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Li J, Lu L, Liu Y, Yu X. Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events. J Mol Med. 2022;100(2):167-183. doi: https://doi.org/10.1007/s00109-021-02164-1</mixed-citation><mixed-citation xml:lang="en">Li J, Lu L, Liu Y, Yu X. Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events. J Mol Med. 2022;100(2):167-183. doi: https://doi.org/10.1007/s00109-021-02164-1</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science (80-). 2013;339(6116):172-177. doi: https://doi.org/10.1126/science.1230721</mixed-citation><mixed-citation xml:lang="en">Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science (80-). 2013;339(6116):172-177. doi: https://doi.org/10.1126/science.1230721</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Choi S. Glycogen as regulator of white fat browning. A new stady on the relationship between glycogen metabolism and thermogenesis. Mol Cells. 2022;45(4):177-179. doi: https://doi.org/10.14348/molcells.2022.2050</mixed-citation><mixed-citation xml:lang="en">Choi S. Glycogen as regulator of white fat browning. A new stady on the relationship between glycogen metabolism and thermogenesis. Mol Cells. 2022;45(4):177-179. doi: https://doi.org/10.14348/molcells.2022.2050</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Chitraju C, Fischer AW, Farese RV, Walther TC. Lipid droplets in brown adipose tissue are dispensable for coldinduced thermogenesis. Cell Rep. 2020;33(5):108348. doi: https://doi.org/10.1016/j.celrep.2020.108348</mixed-citation><mixed-citation xml:lang="en">Chitraju C, Fischer AW, Farese RV, Walther TC. Lipid droplets in brown adipose tissue are dispensable for coldinduced thermogenesis. Cell Rep. 2020;33(5):108348. doi: https://doi.org/10.1016/j.celrep.2020.108348</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Cummings BP, Bettaieb A, Graham JL, et al. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats. Proc Natl Acad Sci. 2011;108(35):14670-14675. doi: https://doi.org/10.1073/pnas.1107163108</mixed-citation><mixed-citation xml:lang="en">Cummings BP, Bettaieb A, Graham JL, et al. Subcutaneous administration of leptin normalizes fasting plasma glucose in obese type 2 diabetic UCD-T2DM rats. Proc Natl Acad Sci. 2011;108(35):14670-14675. doi: https://doi.org/10.1073/pnas.1107163108</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kadowaki T, Yamanuchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784-1792. doi: https://doi.org/10.1172/JCI29126</mixed-citation><mixed-citation xml:lang="en">Kadowaki T, Yamanuchi T, Kubota N, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116(7):1784-1792. doi: https://doi.org/10.1172/JCI29126</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Acquarone E, Monacelli F, Borghi R, et al. Resistin: A reappraisal. Mech Ageing Dev. 2019;178(7):46-63. doi: https://doi.org/10.1016/j.mad.2019.01.004</mixed-citation><mixed-citation xml:lang="en">Acquarone E, Monacelli F, Borghi R, et al. Resistin: A reappraisal. Mech Ageing Dev. 2019;178(7):46-63. doi: https://doi.org/10.1016/j.mad.2019.01.004</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Chen C, Zhou N, et al. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta. 2019;489:183-188. doi: https://doi.org/10.1016/j.cca.2017.10.034</mixed-citation><mixed-citation xml:lang="en">Zhang L, Chen C, Zhou N, et al. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride. Clin Chim Acta. 2019;489:183-188. doi: https://doi.org/10.1016/j.cca.2017.10.034</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Jialal I, Devaraj S, Kaur H, et al. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013;98(3):E514-E517. doi: https://doi.org/10.1210/jc.2012-3673</mixed-citation><mixed-citation xml:lang="en">Jialal I, Devaraj S, Kaur H, et al. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013;98(3):E514-E517. doi: https://doi.org/10.1210/jc.2012-3673</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Arner P, Pettersson A, Mitchell PJ, et al. FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity. FEBS Lett. 2008;582(12):1725-1730. doi: https://doi.org/10.1016/j.febslet.2008.04.038</mixed-citation><mixed-citation xml:lang="en">Arner P, Pettersson A, Mitchell PJ, et al. FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity. FEBS Lett. 2008;582(12):1725-1730. doi: https://doi.org/10.1016/j.febslet.2008.04.038</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Wu H-T, Lu F-H, Ou H-Y, et al. The role of Hepassocin in the development of non-alcoholic fatty liver disease. J Hepatol. 2013;59(5):1065-1072. doi: https://doi.org/10.1016/j.jhep.2013.06.004</mixed-citation><mixed-citation xml:lang="en">Wu H-T, Lu F-H, Ou H-Y, et al. The role of Hepassocin in the development of non-alcoholic fatty liver disease. J Hepatol. 2013;59(5):1065-1072. doi: https://doi.org/10.1016/j.jhep.2013.06.004</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Pal D, Dasgupta S, Kundu R, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012;18(8):1279-1285. doi: https://doi.org/10.1038/nm.2851</mixed-citation><mixed-citation xml:lang="en">Pal D, Dasgupta S, Kundu R, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012;18(8):1279-1285. doi: https://doi.org/10.1038/nm.2851</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Choi HY, Hwang SY, Lee CH, et al. increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. Diabetes Metab J. 2013;37(1):63. doi: https://doi.org/10.4093/dmj.2013.37.1.63</mixed-citation><mixed-citation xml:lang="en">Choi HY, Hwang SY, Lee CH, et al. increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. Diabetes Metab J. 2013;37(1):63. doi: https://doi.org/10.4093/dmj.2013.37.1.63</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C, Feng X, Li Q, et al. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine. 2016;86(1):100-109. doi: https://doi.org/10.1016/j.cyto.2016.06.028</mixed-citation><mixed-citation xml:lang="en">Liu C, Feng X, Li Q, et al. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine. 2016;86(1):100-109. doi: https://doi.org/10.1016/j.cyto.2016.06.028</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Jager J, Grémeaux T, Cormont M, et al. Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression. Endocrinology. 2007;148(1):241-251. doi: https://doi.org/10.1210/en.2006-0692</mixed-citation><mixed-citation xml:lang="en">Jager J, Grémeaux T, Cormont M, et al. Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression. Endocrinology. 2007;148(1):241-251. doi: https://doi.org/10.1210/en.2006-0692</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Timper K, Denson JL, Steculorum SM, et al. IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling. Cell Rep. 2017;19(2):267-280. doi: https://doi.org/10.1016/j.celrep.2017.03.043</mixed-citation><mixed-citation xml:lang="en">Timper K, Denson JL, Steculorum SM, et al. IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling. Cell Rep. 2017;19(2):267-280. doi: https://doi.org/10.1016/j.celrep.2017.03.043</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116(6):1494-1505. doi: https://doi.org/10.1172/JCI26498</mixed-citation><mixed-citation xml:lang="en">Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006;116(6):1494-1505. doi: https://doi.org/10.1172/JCI26498</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance. J Clin Endocrinol Metab. 2013;98(4):E769-E778. doi: https://doi.org/10.1210/jc.2012-2749</mixed-citation><mixed-citation xml:lang="en">Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance. J Clin Endocrinol Metab. 2013;98(4):E769-E778. doi: https://doi.org/10.1210/jc.2012-2749</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang LQ, Franck N, Egan B, et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am J Physiol Metab. 2013;305(11):E1359-E1366. doi: https://doi.org/10.1152/ajpendo.00236.2013</mixed-citation><mixed-citation xml:lang="en">Jiang LQ, Franck N, Egan B, et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am J Physiol Metab. 2013;305(11):E1359-E1366. doi: https://doi.org/10.1152/ajpendo.00236.2013</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen AR, Hojman P, Erikstrup C, et al. Association between Interleukin-15 and obesity: Interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab. 2008;93(11):4486-4493. doi: https://doi.org/10.1210/jc.2007-2561</mixed-citation><mixed-citation xml:lang="en">Nielsen AR, Hojman P, Erikstrup C, et al. Association between Interleukin-15 and obesity: Interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab. 2008;93(11):4486-4493. doi: https://doi.org/10.1210/jc.2007-2561</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Liu D, Mosialou I, Liu J. Bone: Another potential target to treat, prevent and predict diabetes. Diabetes, Obes Metab. 2018;20(8):1817-1828. doi: https://doi.org/10.1111/dom.13330</mixed-citation><mixed-citation xml:lang="en">Liu D, Mosialou I, Liu J. Bone: Another potential target to treat, prevent and predict diabetes. Diabetes, Obes Metab. 2018;20(8):1817-1828. doi: https://doi.org/10.1111/dom.13330</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Si J, Wang C, Zhang D, et al. Osteopontin in bone metabolism and bone diseases. Med Sci Monit. 2020;(26):e919159. doi: https://doi.org/10.12659/MSM.919159</mixed-citation><mixed-citation xml:lang="en">Si J, Wang C, Zhang D, et al. Osteopontin in bone metabolism and bone diseases. Med Sci Monit. 2020;(26):e919159. doi: https://doi.org/10.12659/MSM.919159</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Cipriani C, Colangelo L, Santori R, et al. The interplay between bone and glucose metabolism. Front Endocrinol (Lausanne). 2020;(11):122. doi: https://doi.org/10.3389/fendo.2020.00122</mixed-citation><mixed-citation xml:lang="en">Cipriani C, Colangelo L, Santori R, et al. The interplay between bone and glucose metabolism. Front Endocrinol (Lausanne). 2020;(11):122. doi: https://doi.org/10.3389/fendo.2020.00122</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Ricart W, Fernández-Real JM. La resistencia a la insulina como mecanismo de adaptación durante la evolución humana. Endocrinol Nutr. 2010;57(8):381-390. doi: https://doi.org/10.1016/j.endonu.2010.05.003</mixed-citation><mixed-citation xml:lang="en">Ricart W, Fernández-Real JM. La resistencia a la insulina como mecanismo de adaptación durante la evolución humana. Endocrinol Nutr. 2010;57(8):381-390. doi: https://doi.org/10.1016/j.endonu.2010.05.003</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Li C, Xu MM, Wang K, et al. Macrophage polarization and meta-inflammation. Transl Res. 2018;191(8):29-44. doi: https://doi.org/10.1016/j.trsl.2017.10.004</mixed-citation><mixed-citation xml:lang="en">Li C, Xu MM, Wang K, et al. Macrophage polarization and meta-inflammation. Transl Res. 2018;191(8):29-44. doi: https://doi.org/10.1016/j.trsl.2017.10.004</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Nagao K, Inoue N, Suzuki K, et al. The cholesterol metabolite cholest-5-en-3-one alleviates hyperglycemia and hyperinsulinemia in obese (db/db) mice. Metabolites. 2021;12(1):26. doi: https://doi.org/10.3390/metabo12010026</mixed-citation><mixed-citation xml:lang="en">Nagao K, Inoue N, Suzuki K, et al. The cholesterol metabolite cholest-5-en-3-one alleviates hyperglycemia and hyperinsulinemia in obese (db/db) mice. Metabolites. 2021;12(1):26. doi: https://doi.org/10.3390/metabo12010026</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Graf C, Ferrari N. Metabolic health — the role of adipo-myokines. Int J Mol Sci. 2019;20(24):6159. doi: https://doi.org/10.3390/ijms20246159</mixed-citation><mixed-citation xml:lang="en">Graf C, Ferrari N. Metabolic health — the role of adipo-myokines. Int J Mol Sci. 2019;20(24):6159. doi: https://doi.org/10.3390/ijms20246159</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Klein D, Álvarez-Cubela S, Lanzoni G, et al. BMP-7 induces adult human pancreatic exocrine-to-endocrine conversion. Diabetes. 2015;64(12):4123-4134. doi: https://doi.org/10.2337/db15-0688</mixed-citation><mixed-citation xml:lang="en">Klein D, Álvarez-Cubela S, Lanzoni G, et al. BMP-7 induces adult human pancreatic exocrine-to-endocrine conversion. Diabetes. 2015;64(12):4123-4134. doi: https://doi.org/10.2337/db15-0688</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Zickler M, Stanelle-Bertram S, Ehret S, et al. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. 2022;34(1):1-2. doi: https://doi.org/10.1016/j.cmet.2021.12.002</mixed-citation><mixed-citation xml:lang="en">Zickler M, Stanelle-Bertram S, Ehret S, et al. Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. 2022;34(1):1-2. doi: https://doi.org/10.1016/j.cmet.2021.12.002</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Tsilingiris D, Dalamaga M, Liu J. SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19. Metab Open. 2022;(13):100163. doi: https://doi.org/10.1016/j.metop.2022.100163</mixed-citation><mixed-citation xml:lang="en">Tsilingiris D, Dalamaga M, Liu J. SARS-CoV-2 adipose tissue infection and hyperglycemia: A further step towards the understanding of severe COVID-19. Metab Open. 2022;(13):100163. doi: https://doi.org/10.1016/j.metop.2022.100163</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Cinti F, Cinti S. The Endocrine Adipose Organ: A System Playing a Central Role in COVID-19. Cells. 2022;11(13):2109. doi: https://doi.org/10.3390/cells11132109</mixed-citation><mixed-citation xml:lang="en">Cinti F, Cinti S. The Endocrine Adipose Organ: A System Playing a Central Role in COVID-19. Cells. 2022;11(13):2109. doi: https://doi.org/10.3390/cells11132109</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Gunawardana SC, Piston DW. Insulin-independent reversal of type-1 diabetes following transplantation of adult brown adipose tissue supplemented with IGF-1. Transplant Direct. 2019;5(11):e500. doi: https://doi.org/10.1097/TXD.0000000000000945</mixed-citation><mixed-citation xml:lang="en">Gunawardana SC, Piston DW. Insulin-independent reversal of type-1 diabetes following transplantation of adult brown adipose tissue supplemented with IGF-1. Transplant Direct. 2019;5(11):e500. doi: https://doi.org/10.1097/TXD.0000000000000945</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Yao L, Wang Q, Zhang R, et al. Brown adipose transplantation improves polycystic ovary syndrome-involved metabolome remodeling. Front Endocrinol (Lausanne). 2021;29(12):747-944. doi: https://doi.org/10.3389/fendo.2021.747944</mixed-citation><mixed-citation xml:lang="en">Yao L, Wang Q, Zhang R, et al. Brown adipose transplantation improves polycystic ovary syndrome-involved metabolome remodeling. Front Endocrinol (Lausanne). 2021;29(12):747-944. doi: https://doi.org/10.3389/fendo.2021.747944</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Tsagkaraki E, Nicoloro SM, DeSouza T, et al. CRISPRenhanced human adipocyte browning as cell therapy for metabolic disease. Nat Commun. 2021;12(1):6931. doi: https://doi.org/10.1038/s41467-021-27190-y</mixed-citation><mixed-citation xml:lang="en">Tsagkaraki E, Nicoloro SM, DeSouza T, et al. CRISPRenhanced human adipocyte browning as cell therapy for metabolic disease. Nat Commun. 2021;12(1):6931. doi: https://doi.org/10.1038/s41467-021-27190-y</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
